Cytotoxic biotransformed products from triptonide by Aspergillus niger

Planta Med. 2003 Sep;69(9):804-8. doi: 10.1055/s-2003-43220.

Abstract

The diterpenoid triepoxides are the major active constituents of Tripterygium wilfordii with potent antitumor and immune activities. But the strong toxicity of these compounds has restricted their application to a great extent. In order to find more effective compounds with less toxicity, structural modifications of triptonide (1) by Aspergillus niger (AS 3.739) were investigated and four biotransformed products were obtained. Based on their chemical and spectral data, their structures were elucidated as 5alpha-hydroxytriptonide (2), triptolide (3), 17-hydroxytriptonide (4), and 16-hydroxytriptonide (5), among which 2, 4 and 5 are new compounds. All the three new transformed products showed cytotoxic activities against the majority of the human tumor cell lines tested, however, they are found to possess less cytotoxic activity when compared with 1. Both compounds 4 and 5 showed similar cytotoxic activity and their IC (50) values were 5-15 fold less than 1, while 2 is about 100 times less active than 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / pharmacokinetics
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Aspergillus niger*
  • Biotransformation
  • Cell Line, Tumor / drug effects
  • Humans
  • Inhibitory Concentration 50
  • Phytotherapy*
  • Plant Extracts / administration & dosage
  • Plant Extracts / pharmacokinetics
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Triterpenes / administration & dosage
  • Triterpenes / pharmacokinetics
  • Triterpenes / pharmacology*
  • Triterpenes / therapeutic use

Substances

  • Antineoplastic Agents, Phytogenic
  • Plant Extracts
  • Triterpenes
  • triptonide